Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin

被引:55
作者
Milewski, Mikolaj [1 ]
Brogden, Nicole K. [1 ]
Stinchcomb, Audra L. [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA
关键词
TRANSDERMAL DRUG-DELIVERY; STRATUM-CORNEUM; BARRIER FUNCTION; IN-VIVO; PERMEABILITY; ARRAYS; NANOPARTICLES; LIPOSOMES; INSERTION; RECOVERY;
D O I
10.1517/17425241003663228
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Importance of the field: The efficacy of microneedles in the area of transdermal drug delivery is well documented. Multiple studies have shown that enhancement of skin permeation by means of the creation of microscopic pores in the stratum corneum can greatly improve the delivery rates of drugs. However, skin pretreatment with microneedles is not the only factor affecting drug transport rates. Other factors, including drug formulation and rate of micropore closure, are also important for optimizing delivery by this route. Areas covered in this review: This review aims to highlight work that has been done in these areas, with an emphasis on drug formulation parameters that affect transdermal flux. What the reader will gain: This review creates an appreciation for the many factors affecting microneedle-enhanced delivery. Most results clearly indicate that microneedle skin pretreatment by itself may have different effects on drug transport depending on the formulation used, and formulation characteristics have different effects on the transport through untreated skin and microneedle-treated skin. Several formulation approaches are reported to optimize microneedle-enhanced drug delivery, including co-solvent use, vesicular, nanoparticulate and gel systems. Take home message: In addition to well-established factors that affect microneedle-assisted delivery (geometry, type of microneedle, etc.), formulation and pore viability are also critical factors that must be considered.
引用
收藏
页码:617 / 629
页数:13
相关论文
共 47 条
[1]
Modelling transdermal delivery of high molecular weight drugs from microneedle systems [J].
Al-Qallaf, Barrak ;
Das, Diganta Bhusan ;
Mori, Daisuke ;
Cui, Zhanfeng .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES, 2007, 365 (1861) :2951-2967
[2]
Al-Qallaf B, 2009, J DRUG TARGET, V17, P108, DOI [10.1080/10611860802472370, 10.1080/10611860802472370 ]
[3]
Optimizing Microneedle Arrays to Increase Skin Permeability for Transdermal Drug Delivery [J].
Al-Qallaf, Barrak ;
Das, Diganta Bhusan .
INTERDISCIPLINARY TRANSPORT PHENOMENA: FLUID, THERMAL, BIOLOGICAL, MATERIALS, AND SPACE SCIENCES, 2009, 1161 :83-94
[4]
Micro-scale devices for transdermal drug delivery [J].
Arora, Anubhav ;
Prausnitz, Mark R. ;
Mitragotri, Samir .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (02) :227-236
[5]
Skin penetration enhancement by a microneedle device (Dermaroller®) in vitro: Dependency on needle size and applied formulation [J].
Badran, M. M. ;
Kuntsche, J. ;
Fahr, A. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (4-5) :511-523
[6]
In vivo visualization of microneedle conduits in human skin using laser scanning microscopy [J].
Bal, S. ;
Kruithof, A. C. ;
Liebl, H. ;
Tomerius, M. ;
Bouwstra, J. ;
Lademann, J. ;
Meinke, M. .
LASER PHYSICS LETTERS, 2010, 7 (03) :242-246
[7]
Banga AK, 2009, EXPERT OPIN DRUG DEL, V6, P343, DOI [10.1517/17425240902841935, 10.1517/17425240902841935 ]
[8]
BANKS S, 2010, J PHARM SCI
[9]
Banks S. L., 2008, AAPS J, P10
[10]
Flux across of microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro [J].
Banks, Stan L. ;
Pinninti, Raghotham R. ;
Gill, Harvinder S. ;
Crooks, Peter A. ;
Prausnitz, Mark R. ;
Stinchcomb, Audra L. .
PHARMACEUTICAL RESEARCH, 2008, 25 (07) :1677-1685